Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:FTXHNYSEARCA:GDOCNYSEARCA:MEDINASDAQ:MEDX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeFTXHFirst Trust Nasdaq Pharmaceuticals ETF$26.31+0.0%$25.56$23.29▼$29.72$14.47M0.556,663 shs409 shsGDOCGoldman Sachs Future Health Care Equity ETF$31.85+0.2%$31.37$28.34▼$37.23$19.87M0.841,627 shs153 shsMEDIHarbor Health Care ETF$26.690.0%$25.55$21.86▼$28.40$16.00M12,123 shs470 shsMEDXHorizon Kinetics Medical ETF$27.43+0.3%$26.37$23.46▼$32.00$15.64M0.911,303 shs17 shs20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceFTXHFirst Trust Nasdaq Pharmaceuticals ETF0.00%+3.04%+2.23%+4.65%-1.66%GDOCGoldman Sachs Future Health Care Equity ETF0.00%+0.76%+1.43%+8.22%-8.13%MEDIHarbor Health Care ETF0.00%+0.83%+3.45%+15.09%+6.24%MEDXHorizon Kinetics Medical ETF0.00%+2.99%+3.12%+8.40%-6.95%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AN/AN/AN/AN/AN/AN/AN/AGDOCGoldman Sachs Future Health Care Equity ETFN/AN/AN/AN/AN/AN/AN/AN/AMEDIHarbor Health Care ETFN/AN/AN/AN/AN/AN/AN/AN/AMEDXHorizon Kinetics Medical ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceFTXHFirst Trust Nasdaq Pharmaceuticals ETF 2.58Moderate Buy$26.31N/AGDOCGoldman Sachs Future Health Care Equity ETF 2.79Moderate Buy$31.85N/AMEDIHarbor Health Care ETF 2.87Moderate Buy$26.69N/AMEDXHorizon Kinetics Medical ETF 2.65Moderate Buy$27.43N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AN/AN/AN/AN/AN/AGDOCGoldman Sachs Future Health Care Equity ETFN/AN/AN/AN/AN/AN/AMEDIHarbor Health Care ETFN/AN/AN/AN/AN/AN/AMEDXHorizon Kinetics Medical ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AN/A14.51∞N/AN/AN/AN/AN/AGDOCGoldman Sachs Future Health Care Equity ETFN/AN/A28.36∞N/AN/AN/AN/AN/AMEDIHarbor Health Care ETFN/AN/A37.56∞N/AN/AN/AN/AN/AMEDXHorizon Kinetics Medical ETFN/AN/A22.89∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthFTXHFirst Trust Nasdaq Pharmaceuticals ETF$0.441.67%N/AN/AN/AGDOCGoldman Sachs Future Health Care Equity ETFN/A0.02%N/AN/AN/AMEDIHarbor Health Care ETF$0.130.49%N/AN/AN/AMEDXHorizon Kinetics Medical ETF$0.501.82%N/AN/AN/ALatest MEDI, MEDX, FTXH, and GDOC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/25/2025FTXHFirst Trust Nasdaq Pharmaceuticals ETFQuarterly$0.08921.39%6/26/20256/26/20256/30/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AGDOCGoldman Sachs Future Health Care Equity ETFN/AMEDIHarbor Health Care ETFN/AMEDXHorizon Kinetics Medical ETF62.18%Insider OwnershipCompanyInsider OwnershipFTXHFirst Trust Nasdaq Pharmaceuticals ETFN/AGDOCGoldman Sachs Future Health Care Equity ETFN/AMEDIHarbor Health Care ETFN/AMEDXHorizon Kinetics Medical ETF4.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableFTXHFirst Trust Nasdaq Pharmaceuticals ETF147,000550,002N/AOptionableGDOCGoldman Sachs Future Health Care Equity ETFN/A625,000N/ANot OptionableMEDIHarbor Health Care ETFN/A600,000N/ANot OptionableMEDXHorizon Kinetics Medical ETFN/A570,000N/ANot OptionableMEDI, MEDX, FTXH, and GDOC HeadlinesRecent News About These CompaniesHorizon Kinetics Holding Corporation Reports First Quarter ResultsMay 14, 2025 | accessnewswire.comAHorizon Kinetics Holding Corporation Reports Fourth Quarter and Annual ResultsMarch 26, 2025 | accessnewswire.comAETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts OutlookMay 1, 2024 | zacks.comHorizon Kinetics ISE Wealth (RCH)May 13, 2023 | uk.investing.comHORIZON Fushi ChinaA 50 ETF (512150)May 11, 2023 | investing.comHorizon Kinetics Launches the Horizon Kinetics SPAC Active ETF (SPAQ) and the Horizon Kinetics Medical ETF (MEDX)April 19, 2023 | finance.yahoo.comMedia Sentiment Over TimeTop HeadlinesView All HeadlinesMid-Cap Marvels: 3 Stocks That Crushed Sales Estimates in MayBy Leo Miller | June 12, 2025View Mid-Cap Marvels: 3 Stocks That Crushed Sales Estimates in MaySalesforce Raises Prices: 3 Reasons Its Stock Price Will FollowBy Thomas Hughes | June 18, 2025View Salesforce Raises Prices: 3 Reasons Its Stock Price Will Follow3 Medical Technology Stocks Outperforming in 2025By Ryan Hasson | June 9, 2025View 3 Medical Technology Stocks Outperforming in 2025Buybacks Galore: Repurchases From the Oval Office to Olive GardenBy Leo Miller | June 30, 2025View Buybacks Galore: Repurchases From the Oval Office to Olive Garden3 High-Growth Stocks Traders Love and Investors Should WatchBy Chris Markoch | June 5, 2025View 3 High-Growth Stocks Traders Love and Investors Should WatchMEDI, MEDX, FTXH, and GDOC Company DescriptionsFirst Trust Nasdaq Pharmaceuticals ETF NASDAQ:FTXH$26.30 +0.01 (+0.02%) As of 07/3/2025 01:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.Goldman Sachs Future Health Care Equity ETF NYSEARCA:GDOC$31.85 +0.06 (+0.19%) As of 07/3/2025 05:00 PM EasternThe Goldman Sachs Future Health Care Equity ETF (GDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to equities of companies that are driving innovation in healthcare globally. GDOC was launched on Nov 9, 2021 and is managed by Goldman Sachs.Harbor Health Care ETF NYSEARCA:MEDI$26.69 -0.01 (-0.04%) As of 07/3/2025 05:00 PM EasternThe Harbor Health Care ETF (MEDI) is an exchange-traded fund that is based on the Russell 3000 Growth Health Care index. The fund seeks long-term capital growth by actively managing a narrow portfolio of stocks engaged in the health care sector globally. MEDI was launched on Nov 16, 2022 and is managed by Harbor.Horizon Kinetics Medical ETF NASDAQ:MEDX$27.43 +0.07 (+0.26%) As of 07/3/2025 02:20 PM EasternThe Horizon Kinetics Medical ETF (MEDX) is an exchange-traded fund that mostly invests in health care equity. The fund actively invests in global companies within the broad health care sector. Stock selection and weighting emphasizes those invested in cancer research and pharmaceutical developments. MEDX was launched on Jan 27, 2023 and is managed by Horizon Kinetics. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
